antiviral peptideTherapeutic Peptides
Enfuvirtide (Fuzeon)
A 36-amino acid synthetic peptide that inhibits HIV-1 fusion with host cells by binding to gp41. FDA-approved (2003) as first-in-class HIV fusion inhibitor. Used in treatment-experienced patients with drug-resistant HIV.
antiviralHIV-treatmentfusion-inhibitorFDA-approved
3D Structure
3D Structure
4491.93 Da
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A 36-amino acid synthetic peptide that inhibits HIV-1 fusion with host cells by binding to gp41. FDA-approved (2003) as first-in-class HIV fusion inhibitor. Used in treatment-experienced patients with…